For more information:
[1] Rack B, Schindlbeck C, J?ckstock J, Andergassen U, Hepp P, Zwingers T, Friedl TWP, et al. Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients. J Natl Cancer Inst. 2014 May 15. pii: dju066. [Epub ahead of print] doi: 10.1093/jnci/dju066.[Article][PubMed]
[2]Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as well as Extended Bisphosphonate and Surveillance trial –
EudraCT Number: 2005-000490-21 Sponsor Protocol Number: SUCCESS Start Date: 2005-08-24 [Trial]
[3]Schwartz AM, Nolan N. Circulating Tumor Cells: What Goes Around, Comes Around. J Natl Cancer Inst. 2014 May 15. pii: dju108.[Article][PubMed]
Home Rack B, Schindlbeck C, J?ckstock J
